Showing 811-820 of 3001 results for "".
Onabotulinumtoxin A for Headache: An Update
https://practicalneurology.com/diseases-diagnoses/headache-pain/onabotulinumtoxin-a-for-headache-an-update/30783/A year after FDA approval, a specialist offers an update on neurotoxin therapy for migraine and headache.Filling the Gap in Pediatric Neurology
https://practicalneurology.com/diseases-diagnoses/child-neurology/filling-the-gap-in-pediatric-neurology/30265/The view from an area without pediatric neurologists.A Practical Evaluation of Migraine Trigger Site Deactivation Surgery
https://practicalneurology.com/diseases-diagnoses/headache-pain/a-practical-evaluation-of-migraine-trigger-site-deactivation/30696/An analysis of the data casts doubt on the purported benefits of MTSDS.Degenerative Cervical Myelopathy as a Neuromuscular Mimicker
https://practicalneurology.com/diseases-diagnoses/neuromuscular/degenerative-cervical-myelopathy-as-a-neuromuscular-mimicker/33147/The authors detail a practical approach to the assessment of individuals with suspected degenerative cervical myelopathy.Respiratory Therapy for Neuromuscular Disorders
https://practicalneurology.com/diseases-diagnoses/neuromuscular/respiratory-therapy-for-neuromuscular-disorders/31923/Specific interventions are available to support respiratory function at different stages of respiratory decline in chronic neuromuscular disorders.Addressing Alzheimer's Disease: Target 2025
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/addressing-alzheimers-disease-target-2025/30631/The Alzheimer's Association takes an in-depth look at the US National Plan to Address Alzheimer's Disease, which seeks to prevent and effectively treat Alzheimer's disease by 2025.SmartCare: How New Technologies Are Changing the Parkinson's Spectrum
https://practicalneurology.com/diseases-diagnoses/movement-disorders/smartcare-how-new-technologies-are-changing-the-parkinsons-spectrum/30472/News
https://practicalneurology.com/archives/2014-june/news/30653/Movement Disorders Focus: Harnessing Existing Drugs to Slow Progression of Parkinson's Disease: The STEADY-PDIII Trial of Isradipine
https://practicalneurology.com/diseases-diagnoses/movement-disorders/harnessing-existing-drugs-to-slow-progression-of-parkinsons-disease-the-steady-pdiii-trial-of-isradipine/30654/Marijuana Use and Ischemic Stroke
https://practicalneurology.com/columns/practice-management/marijuana-use-and-ischemic-stroke/30705/